Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.47 USD | +1.30% | +7.10% | +1.72% |
03-20 | Myriad Genetics Gets US Patent for SneakPeek Snap Device | MT |
02-27 | Transcript : Myriad Genetics, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.72% | 1.74B | |
-1.89% | 12.5B | |
-9.59% | 7.67B | |
+21.82% | 5.36B | |
-1.31% | 5.26B | |
+0.02% | 4.57B | |
-50.89% | 3.15B | |
+6.42% | 2.59B | |
-10.02% | 2.06B | |
-8.29% | 1.79B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics : Goldman Sachs Starts Myriad Genetics at Sell With $25 Price Target